Showing 1 – 20 of 4656
SORT: Best Match Most Recent Oldest
VIEW: Basic | Expanded
  • Original Contribution November 26, 2003

    Robert Rosenheck, MD; Deborah Perlick, PhD; Stephen Bingham, PhD; Wen Liu-Mares, PhD; Joseph Collins, ScD; Stuart Warren, JD, PharmD; Douglas Leslie, PhD; Edward Allan, MD; E. Cabrina Campbell, MD; Stanley Caroff, MD; June Corwin, PhD; Lori Davis, MD; Richard Douyon, MD; Lawrence Dunn, MD; Denise Evans, MD; Ede Frecska, MD; John Grabowski, MD; David Graeber, MD; Lawrence Herz, MD; Kong Kwon, MD; William Lawson, MD; Felicitas Mena, MD; Javaid Sheikh, MD; David Smelson, PhD; Valerie Smith-Gamble, MD; for the Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine
    TOPICS: haloperidol, schizophrenia, olanzapine

    JAMA. 2003; 290(20):2693-2702. doi: 10.1001/jama.290.20.2693